Recruitment unclearEUCTR 2020-000341-14

A Double-Blind, Randomized, Parallel-Group Study with Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in ...

This historical record does not confirm current site availability.

Historical research recordMultiple countriesDepression

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium · Bulgaria and 6 more locations
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Recruitment unclear
Enrollment listed in the registry: 720
Sponsor: Janssen-Cilag International NV
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United Kingdom, Belgium, Bulgaria, ...
Age range: Not clearly listed
Official registry ID: EUCTR 2020-000341-14
Official title: Show the full official title
A Double-Blind, Randomized, Parallel-Group Study with Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in ...

Questions about this study?

The HopeStage team will email you.

Recruitment & locations

Status unknown

Belgium · Bulgaria · Czechia

5 more locations

Latvia
Lithuania
Poland
Slovakia
United Kingdom

Registry details

Historical country statuses

Belgium — Completed
Bulgaria — Completed
Czechia — Completed
United Kingdom — GB - no longer in EU/EEA
Lithuania — Completed
Latvia — Completed
Poland — Completed
Slovakia — Completed

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag International NV.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me